Molecular

Latest Posts

On Thursday, BMO Capital Markets sustained its optimistic stance on 4D Molecular Therapeutics (NASDAQ:FDMT),...

Market

BMO Capital sticks with $40 goal for 4D Molecular inventory as 4D-150 PhIII prospects stay sturdy By Investing.com

Disclaimer: This can be a sponsored press release. Readers ought to conduct their very...

Press Release

Molecular Future (MOF) Showcasing Outstanding Journey: From a $20 Million Milestone to Conquering Challenges – Coin Trolly